Exploring how genetic variations affect RNA decay processes
Understanding the variability in nonsense-mediated RNA decay
This study is looking at how the way our bodies break down a type of genetic material called mRNA can affect whether certain genetic changes lead to diseases, helping us understand genetic disorders better and improve treatments for people with these conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-11011142 on NIH RePORTER |
What this research studies
This research investigates how differences in the decay of messenger RNA (mRNA) can influence the effects of genetic variations in humans. By examining how certain genetic mutations, particularly nonsense variants, are processed by the body's RNA quality control mechanisms, the research aims to uncover why some genetic changes lead to diseases while others do not. The approach involves advanced techniques like massively parallel reporter assays and targeted gene editing to identify factors that affect RNA decay efficiency. This knowledge could enhance our understanding of genetic disorders and improve precision medicine.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with known genetic variants, particularly those with nonsense mutations that may affect gene function.
Not a fit: Patients without genetic variations or those with conditions unrelated to nonsense-mediated RNA decay may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better predictions of how genetic variations impact health, potentially guiding more effective treatments for genetic disorders.
How similar studies have performed: Previous research has shown promise in understanding RNA decay mechanisms, but this specific approach to studying variability in nonsense-mediated decay is relatively novel.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Jagannathan, Sujatha — University of Colorado Denver
- Study coordinator: Jagannathan, Sujatha
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.